Trial intelligence / Profile preview

Vonoprazan versus lansoprazole for proteinuria in diabetic kidney disease

PACTR202411502424899Completed

Sponsor
Cairo University
Start
Jan 2024
Modality
Small Molecules
Countries
1
01

Overview

Trial of vonoprazan and lansoprazole in diabetic glomerulosclerosis, sponsored by Cairo University. Started Jan 2024; status: completed.

02

Drugs

vonoprazanlansoprazole
03

Conditions

diabetic glomerulosclerosis

Beyond the preview

Go deeper on PACTR202411502424899.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202411502424899.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call